Parallel import of in vitro diagnostic medical devices
Judgment of the Court of Justice of the European Union (CJEU), of 13 October 2016, (Case C-277/15, Roche Diagnostics Deutschland GmbH vs Servoprax GmbH)
CAPSULAS Nº 175
Background Roche Diagnostics markets in vitro diagnostic medical devices in Germany. Servoprax purchased said devices in the United Kingdom, where they were also marketed, and then added a label and instructions in German and sold them in Germany. The product’s label in Germany made reference to two units of measurement (“mmol/l” and “mg/dl”), whilst in... Read More
Los tribunales acotan las injerencias en la libertad de prescripción
EL GLOBAL
Nuestro ordenamiento jurídico consagra la libertad de prescripción del facultativo a través de la Ley de garantías y uso racional de los medicamentos y productos sanitarios, cuyo artículo 79 dispone que médicos, odontólogos y podólogos son los únicos profesionales facultados para instaurar un tratamiento con medicamentos de prescripción. Conviene matizar, no obstante, que dicha libertad... Read More
Competencia, OPEP y medicamentos
EL GLOBAL
Al regresar de sus vacaciones de verano, una de las primeras sentencias que dictó el Tribunal General de la Unión Europea tuvo por objeto el recurso presentado por Lundbeck contra la decisión de la Comisión de 19 de junio de 2013, que la declaraba culpable de infringir las normas sobre libre competencia y le imponía... Read More
Risks in the agreements between patent holders and generic medicinal product companies
Judgment of the General Court of the European Union of 8 September 2016, Case T-472/13, Lundbeck
CAPSULAS Nº 174
Background This extensive judgment (+120 pages) addresses the ruling adopted by the European Commission in June 2013, which declared that Lundbeck, Merck, Arrow, Alpharma and Ranbaxy had infringed European rules on competition when agreeing that Lundbeck would provide economic compensation to the manufacturers of generic medicinal products for not marketing Citalopram in certain territories during... Read More
Significant recent developments in terms of administrative procedure
Law No. 39/2015, of 1 October, on the Common Administrative Procedure of Public Authorities comes into force
CAPSULAS Nº 174
On 2 October, Law No. 39/2015, which regulates the common administrative procedure of Public Authorities (LPAC) comes into force. This Law revokes various other laws and regulations. Amongst the foregoing, the most relevant is Law No. 30/1992, on the Legal System applicable to Public Authorities and Common Administrative Procedure. The legislator, on this occasion, has... Read More
Compensation for the sudden termination of an indefinite term exclusive distribution contract
Judgment of the Supreme Court of 19 July 2016
CAPSULAS Nº 174
Background GP Acustics, a German company dedicated to the production of speakers, notified Ear, S.A., its exclusive distributor in Spain, of its unilateral decision to end the 30-year distribution relationship between the parties with just two months’ notice. Said decision was not based on any breach committed by Ear, rather the wish of GP Acustics... Read More
La Administración Pública del siglo XXI
El Global
Este mes de octubre entrarán en vigor la Ley 39/2015, reguladora del procedimiento administrativo común de las Administraciones Públicas (LPAC) y la Ley 40/2015, reguladora del Régimen Jurídico del Sector Público (LRJSP). Dichas leyes derogan diversas normas de rango legal, la más conocida de ellas la Ley 30/1992, de Régimen Jurídico de las Administraciones Públicas... Read More
Cáncer de próstata, incertidumbre y riesgo compartido
EL GLOBAL
Hace unos días, la prensa británica se hizo eco del resultado de un estudio avalado por el NHS del cual resultaría que los tratamientos más agresivos contra los tumores prostáticos (cirugía o radioterapia) no reportan beneficios significativos en términos de supervivencia. Por contra, como es sabido son tratamientos con importantes efectos adversos. No tengo la... Read More
Faus & Moliner at the IBA Annual Conference in Washington, DC
Jordi Faus participated as a co-moderator at the session about providing and paying for healthcare at the Annual Conference of the International Bar Association
At this year’s Annual Conference of the International Bar Association, which was held in Washington the week of 18-23 of September, the Healthcare and Life Sciences Law Committee has organized a Session under the title “Providing and paying for healthcare: public, private or something in between? Obamacare and beyond”. This session saught to explain the goal of... Read More
Acuerdos de fondo en materia sanitaria
EL GLOBAL
En los últimos años nos hemos acostumbrado a que la Sanidad sea una de las áreas en las que en España se producen más conflictos entre administraciones. Uno de esos conflictos lo ha cerrado reciente una sentencia del Tribunal Constitucional que, a raíz de un recurso presentado por el Parlamento de Navarra frente a diferentes... Read More